StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research note published on Wednesday morning. The firm issued a hold rating on the stock.
Milestone Scientific Price Performance
Shares of MLSS stock opened at $0.87 on Wednesday. The stock has a market capitalization of $67.19 million, a PE ratio of -8.70 and a beta of 1.08. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10. The business has a 50-day moving average of $0.96 and a 200 day moving average of $0.80.
Milestone Scientific (NYSE:MLSS – Get Free Report) last issued its earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The company had revenue of $1.85 million for the quarter. Milestone Scientific had a negative net margin of 54.87% and a negative return on equity of 60.78%.
Insider Transactions at Milestone Scientific
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
- Five stocks we like better than Milestone Scientific
- What is the Nikkei 225 index?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Most active stocks: Dollar volume vs share volume
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Airline Stocks – Top Airline Stocks to Buy Now
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.